An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder

This publication has 13 references indexed in Scilit:

• Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data
  Life Sciences, 1997
• Oxybutynin
  Drugs & Aging, 1995
• Urinary incontinence in the community--analysis of a MORI poll.
  BMJ, 1993
• Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers
  Xenobiotica, 1992
• Current Concepts in the Treatment of Genitourinary Tract Disorders in the Older Individual
  Drugs & Aging, 1991
• Idiopathic bladder hyperactivity treated with Ditropan (oxybutynin chloride)
  International Urology and Nephrology, 1990
• Mini‐pig urinary bladder function: comparisons of in vitro anticholinergic responses and in vivo cystometry with drugs indicated for urinary incontinence
  Journal of Autonomic Pharmacology, 1990
• Etiology and Management of Detrusor Instability and Mixed Incontinence
  Obstetrics and Gynecology Clinics of North America, 1989
• ON THE MUSCARINIC RECEPTORS IN THE URINARY BLADDER AND THE PUTATIVE SUBCLASSIFICATION OF MUSCARINIC RECEPTORS
  Acta Pharmacologica et Toxicologica, 1986
• Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites
  European Journal of Pharmacology, 1986